南财智讯2月11日电，飞鹿股份公告，2026年2月11日，信息披露义务人章卫国与骁光智能签署《终止协 议》，解除其持有的29,966,913股股份（占总股本13.69%）对应的表决权委托。本次权益变动完成后， 章卫国可支配表决权比例由0.00%恢复至13.69%，重新成为公司控股股东及实际控制人；骁光智能可支 配表决权比例相应降至5.02%。本次变动不涉及股份转让、交易对价或资金支付，相关股份不存在质 押、冻结等权利限制情形。章卫国暂无在未来12个月内增持或减持公司股份的计划。 ...

Core Viewpoint - Jihua Group announced that Tonglu Junheng Equity Investment Partnership (Limited Partnership) has acquired a total of 202,308,716 shares from Hangzhou Jinhui and Shao Hui, representing 29.89% of the company's total equity, making it the largest and controlling shareholder of the company after the transaction [1] Summary by Relevant Sections - **Shareholding Change** - Before the transaction, Tonglu Junheng held 0.00% of the shares, which increased to 29.89% post-acquisition [1] - The acquired shares are free from any pledges, freezes, or other rights restrictions [1] - **Future Plans** - Tonglu Junheng and its actual controller, Su Ertian, plan to further increase their stake in the company through the subscription of non-publicly issued shares within the next 12 months [1] - There are plans for a small asset injection that does not constitute a major asset reorganization [1]

Group 1: Change of Controlling Shareholder - The controlling shareholder of Zhuhai Gaoling Information Technology Co., Ltd. has changed its name from Zhuhai Gaoling Technology Investment Co., Ltd. to Zhuhai Mingde Zhenghong Investment Co., Ltd. [1] - The registered capital of the controlling shareholder has increased from 10 million RMB to 30 million RMB [1] - The change in business registration does not affect the number of shares held by the controlling shareholder or the actual controller, and will not impact the company's governance or operations [1] Group 2: Departure of Core Technical Personnel - Core technical personnel Wang Xianfa has resigned for personal reasons and has completed the necessary departure procedures [4][6] - Wang Xianfa's departure will not affect the company's intellectual property rights, as all patents developed during his tenure belong to the company [5][8] - The company has a complete R&D team structure, and Wang Xianfa's responsibilities have been successfully handed over, ensuring no adverse impact on ongoing R&D projects [11][12] Group 3: 2025 Annual Performance Forecast - The company expects to achieve an operating income of 220 million to 242 million RMB in 2025, a decrease of 24.48 million to 46.48 million RMB compared to the previous year, representing a decline of 9.19% to 17.44% [16] - The forecasted net loss attributable to the parent company is expected to be between 33 million and 42.9 million RMB, a reduction of 9.38 million to 19.28 million RMB compared to the previous year, indicating a year-on-year improvement of 17.94% to 36.88% [16] - The company attributes the expected loss reduction to improved inventory turnover efficiency and optimized personnel allocation, despite a decline in operating income and rising raw material costs [19]

Core Viewpoint - The company Tian Sheng New Materials plans to raise no more than 253 million yuan through a private placement of shares, with the net proceeds intended for repaying bank loans and/or supplementing working capital [1] Group 1: Fundraising Details - The company will issue shares to a specific entity, Beijing Rongsheng Zhizhi Technology Development Partnership (Limited Partnership) [1] - The issue price is set at 5.06 yuan per share, with a total of 50 million shares to be subscribed [1] - After the issuance, the controlling shareholder will change to Beijing Rongsheng Zhizhi Technology Development Partnership (Limited Partnership) [1] Group 2: Ownership Changes - Prior to the issuance, the company had no controlling shareholder or actual controller [1] - Following the issuance, the actual controller will change to Wei Lidong [1]

Core Viewpoint - *ST Zhongzhuang announced the implementation of a capital reserve plan to increase its share capital, resulting in a total share count increase from 960,135,993 shares to 1,950,000,000 shares, excluding treasury shares [1] Group 1 - The original controlling shareholders, Zhuang Xiaohong and Zhuang Zhannuo, experienced a dilution in their shareholding percentages, with Zhuang Xiaohong's stake decreasing from 10.34% to 5.10% and Zhuang Zhannuo's from 5.41% to 2.66% [1] - Shanghai Hengcen acquired 312 million shares in the capital increase for 546 million yuan, representing 16% of the total share capital, and is set to complete the transfer by December 30, 2025, becoming the controlling shareholder [1] - Zhuang Xiaohong has relinquished voting rights for 97.5 million shares [1]

Core Viewpoint - The announcement details a significant share transfer involving Mr. Zeng Bensheng and three entities, leading to a change in the controlling shareholder of the company to Hangzhou Pinbianyi Network Technology Co., Ltd. Group 1: Share Transfer Details - Mr. Zeng Bensheng signed a share transfer agreement with Hangzhou Pinbianyi to transfer 19,555,200 shares, representing 19.40% of the total shares of the company [1] - Mr. Zeng also signed agreements with Wenzhou Cangxiao and Hangzhou Runyi to transfer 5,241,600 shares (5.20%) and 5,140,800 shares (5.10%) respectively [1] - The total shares transferred amount to 30,937,600 shares, which is 29.70% of the company's total shares [2] Group 2: Voting Rights and Control Changes - After the share transfer, Mr. Zeng will relinquish voting rights for 26,000,612 shares, which is 25.79% of the total shares [2] - A concerted action agreement was signed among Hangzhou Pinbianyi, Wenzhou Cangxiao, and Hangzhou Runyi, stipulating that they will act in unison regarding shareholder rights [2] - Following the changes, Hangzhou Pinbianyi will become the controlling shareholder, with Mr. Xu Yi as the actual controller of the company [2] Group 3: Stock Resumption - The company has applied for the resumption of its stock trading, which is set to resume on January 5, 2026 [2]

Core Viewpoint - *ST Wanfang is facing significant challenges, including a change in controlling shareholder, ongoing investigations, and declining performance, leading to a sharp drop in stock price and investor confidence [2]. Group 1: Company Performance - The company reported a net profit of -8.59 million yuan for the first three quarters of 2025, a year-on-year decline of 164.64% [2]. - The total market capitalization of *ST Wanfang is 1.563 billion yuan, with a circulating market value of 1.557 billion yuan [1]. Group 2: Regulatory and Compliance Risks - The company is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure, posing a significant risk of forced delisting if financial indicators for 2025 are not met [2]. - The company's ESG rating has declined, with an environmental score of 42.22 (CCC), a social responsibility score of 50.22 (BB), and a governance score of 69.61 (A), reflecting poor performance in these areas [2]. Group 3: Market Sentiment and Investor Behavior - On December 22, 2025, the company was included in the "Dragon and Tiger List," with institutional investors net selling 27.30 million yuan, indicating a lack of confidence in the company's future [2]. - The total trading volume on the day of the stock's limit down was 46.09 million yuan, with a price drop of 4.92% to 5.02 yuan [1].

Group 1 - Fenglong Co., Ltd. announced that its controlling shareholder will change to UBTECH, and the stock will resume trading [12][13] - Victory Energy has experienced a continuous increase in stock price for nine consecutive trading days, with a cumulative increase of 135.86%, and may apply for a trading suspension if the price continues to rise [4] - Dongbai Group issued a stock price fluctuation announcement, indicating potential risks of significant price drops after recent increases [10] Group 2 - Enhua Pharmaceutical's wholly-owned subsidiary signed a $20 million exclusive commercial cooperation agreement with Green Leaf Pharmaceutical for three long-acting antipsychotic products in mainland China, with a sales target of at least 2.7 billion RMB from 2026 to 2035 [2] - Longpan Technology plans to increase the planned production capacity of lithium iron phosphate cathode materials from 62,500 tons per year to 100,000 tons per year [2] - Jiangsu Zhanchin, a company in which Hongda Electronics holds a 13.79% stake, has submitted an IPO application, but the progress remains uncertain [3] Group 3 - Jizhi Co., Ltd. intends to acquire at least 51% of Zhejing Pumai Technology to enhance its capabilities in the robotics sector [4] - Nanshan Aluminum established a wholly-owned subsidiary in Hainan with an investment of 5 million RMB to improve regional industrial layout and expand high-end aluminum product development [5] - Sany Heavy Energy plans to use up to 9.5 billion RMB of its own funds for entrusted wealth management in 2026 [9] Group 4 - Zongtai Automobile reached a settlement with two bank creditors to avoid large financial disputes and facilitate the release of frozen assets [11] - Tianji Co., Ltd. is pushing for the industrialization of lithium sulfide material preparation, but the project faces risks of underperformance [6] - Guangyang Co., Ltd. signed a strategic cooperation agreement with Konghui Automotive to advance its business layout in the intelligent driving sector [7]

以本次股份转让为前提，逐越鸿智或其指定的关联方拟通过部分要约收购的方式进一步增持上市公司的 股份，拟要约收购股份数量为233,491,406股（占公司总股本的25.00%）。同时，根据《股份转让协 议》的相关约定，中包香港不可撤销地承诺，中包香港将以其所持上市公司102,911,441股无限售条件流 通股份（占上市公司股份总数的11.02%）就本次要约收购有效申报预受要约；未经要约方书面同意， 中包香港不得撤回、变更其预受要约。 本次权益变动完成后，公司控股股东及实际控制人将发生变更，公司控股股东将变更为逐越鸿智，实际 控制人将变更为俞浩先生。公司股票（股票简称：嘉美包装，股票代码：002969）将于2025年12月17日 （星期三）上午开市起复牌。 公司股东富新投资有限公司（简称"富新投资"）、中凯投资发展有限公司（简称"中凯投资"）分别与逐 越鸿智签署了《预先接受要约收购的协议》，富新投资、中凯投资拟通过接受逐越鸿智发出的部分要约 方式向其转让其所持上市公司股份及其所对应的所有股东权利和权益。其中，富新投资拟预受要约部分 股票88,991,910股，占公司总股本的9.53%。中凯投资拟预受要约部分股票23 ...

Core Viewpoint - The announcement indicates a significant change in the control of Tailong Pharmaceutical, with Zhengzhou Tai Rong Industrial Investment Co., Ltd. planning to transfer shares to Jiangyao Holdings, leading to a shift in the company's controlling shareholder and actual controller [1][2][4] Group 1: Share Transfer and Control Change - Zhengzhou Tai Rong Industrial Investment Co., Ltd. will transfer 8.73% of Tailong Pharmaceutical's shares to Jiangyao Holdings at a price of 11.043 CNY per share, totaling 553 million CNY [1] - Following the share transfer, Jiangyao Holdings will hold 7.37% of the shares and, through a concerted action arrangement, will control a total of 14.37% of the company [2] - The controlling shareholder will change from Zhengzhou Tai Rong to Jiangyao Holdings, with the actual controller shifting from Zhengzhou High-tech Industrial Development Zone Management Committee to Jiangxi Provincial State-owned Assets Supervision and Administration Commission [2] Group 2: Capital Increase and Fund Utilization - Jiangyao Holdings plans to subscribe for up to 74.6052 million shares of Tailong Pharmaceutical, with the total fundraising not exceeding 454 million CNY, aimed at enhancing working capital and repaying interest-bearing debts [3] - Upon completion of the share transfer and capital increase, Jiangyao Holdings is expected to hold 125 million shares, representing 19.23% of the total share capital post-issuance [3] Group 3: Strategic Implications - The partnership with Jiangyao Holdings is expected to leverage its resources in commercial circulation, retail terminals, and e-commerce to enhance market penetration and sales growth for Tailong Pharmaceutical's existing products [4] - The collaboration aims to integrate resources and competitive advantages in the biopharmaceutical sector, promoting high-quality development and enhancing the company's profitability and competitiveness [4] - The fundraising will provide sufficient operational capital support for Tailong Pharmaceutical's strategic optimization and business layout, helping the company seize industry development opportunities and improve shareholder returns [4]